Mdxhealth to Release Third Quarter 2025 Financial Results on November 12

Core Insights - MDxHealth SA will release its financial results for the third quarter ended September 30, 2025, after market close on November 12, 2025 [1] - A conference call with live Q&A will be held on the same day at 4:30 PM ET / 22:30 CET [2] Company Overview - MDxHealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment [3] - The company's tests are based on proprietary genomic, epigenomic, exosomal, and other molecular signatures, assisting physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases [3] - The U.S. headquarters and laboratory operations are located in Irvine, California, with additional labs in Waltham, Massachusetts, and Plano, Texas; European headquarters are in Herstal, Belgium [3]